Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-012272

Chief Technology Officer sold 7,000 shares at an average $29.20 ($204,370)

  • Chief Technology Officer acquired 7,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myer Vickesh · Chief Technology Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-17 Exercise or conversion : show line 1 in the form +3,000 $0.65 $1,950 3,000 D
2018-10-17 Sale : show line 2 in the form −3,000 $28.87 $86,610 0 D
2018-10-18 Exercise or conversion : show line 3 in the form +4,000 $11.21 $44,840 4,000 D
2018-10-18 Sale : show line 4 in the form −4,000 $29.44 $117,760 0 D
Open-market sales · 7,000 sh · avg $29.20 · $204,370

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-10-17 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −3,000 88,307 D
2018-10-18 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −4,000 64,897 D
Loading xslF345X03/edgar.xml…